WHO ICTRP trial
Bioequivalence study of Diosmin 450 mg + Hesperidin 50 mg film-coated tablet in…
CTRI/2025/02/080636 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/02/080636 |
|---|---|
| Public title | Bioequivalence study of Diosmin 450 mg + Hesperidin 50 mg film-coated tablet in healthy, adult human, subjects under fed conditions. |
| Scientific title | An Open label, balanced, randomized, truncated, two treatment, two-period, two-sequence, single dose, crossover, oral bioequivalence study of Pilestop Tablet (Diosmin 450 mg + Hesperidin 50 mg film-coated tablet) by The ACME Laboratories Ltd., with Daflon 500 Tablet (Diosmin 450 mg + Hesperidin 50… |
| Primary sponsor | The ACME Laboratories Ltd., |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | BA/BE |
| Countries | India |
| Interventions | Intervention1: Pilestop Tablet (Diosmin 450 mg + Hesperidin 50 mg film-coated tablet): Name of the drug: Pilestop Tablet (Diosmin 450 mg + Hesperidin 50 mg film-coated tablet), Route of administration: Oral, Frequency: single oral dose… |
| Registration date | Feb 17, 2025 |
| Target size | 24 |
| Secondary IDs | ICBio/013/0424, Version: 00, Dated: 29 Apr 2024 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: